Literature DB >> 11158170

Two hits revisited again.

I P Tomlinson1, R Roylance, R S Houlston.   

Abstract

INTRODUCTION AND METHODS: Since the concept of the "two hit hypothesis" was introduced over 20 years ago, a wealth of genetic data has accumulated on the mutations found at tumour suppressor loci. Perhaps surprisingly, these data conceal large gaps in our knowledge which genetic and functional studies are beginning to uncover. The "two hit hypothesis" must be updated to take account of this new information. RESULTS AND DISCUSSION: Here, we discuss both the results of recent studies and some of the questions that they highlight. In particular, how valid are conclusions from inherited Mendelian syndromes when applied to sporadic cancers? Why is allelic loss so common and how does it occur? Are the "two hits" random or interdependent? Is abolition of protein function always optimal for tumorigenesis? Can "third hits" occur and, if so, why? How can mismatch repair deficiency and the methylator phenotype be incorporated into the "two hit" hypothesis? We suggest that the "two hit hypothesis" is not fixed but is evolving as our knowledge expands.

Entities:  

Mesh:

Year:  2001        PMID: 11158170      PMCID: PMC1734812          DOI: 10.1136/jmg.38.2.81

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  35 in total

1.  Dominant negative effect of the APC1309 mutation: a possible explanation for genotype-phenotype correlations in familial adenomatous polyposis.

Authors:  S Dihlmann; J Gebert; A Siermann; C Herfarth; M von Knebel Doeberitz
Journal:  Cancer Res       Date:  1999-04-15       Impact factor: 12.701

2.  Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization.

Authors:  S D Pack; B Zbar; E Pak; D O Ault; J S Humphrey; T Pham; K Hurley; R J Weil; W S Park; I Kuzmin; C Stolle; G Glenn; L A Liotta; M I Lerman; R D Klausner; W M Linehan; Z Zhuang
Journal:  Cancer Res       Date:  1999-11-01       Impact factor: 12.701

3.  Interindividual variation in mitotic recombination.

Authors:  D Holt; M Dreimanis; M Pfeiffer; F Firgaira; A Morley; D Turner
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

4.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

Review 5.  Cancer epigenetics comes of age.

Authors:  P A Jones; P W Laird
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

6.  The cylindromatosis gene (cyld1) on chromosome 16q may be the only tumour suppressor gene involved in the development of cylindromas.

Authors:  P J Biggs; P Chapman; S R Lakhani; J Burn; M R Stratton
Journal:  Oncogene       Date:  1996-03-21       Impact factor: 9.867

7.  Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps.

Authors:  L N Spirio; W Samowitz; J Robertson; M Robertson; R W Burt; M Leppert; R White
Journal:  Nat Genet       Date:  1998-12       Impact factor: 38.330

8.  Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation.

Authors:  H Zhou; J Kuang; L Zhong; W L Kuo; J W Gray; A Sahin; B R Brinkley; S Sen
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

9.  The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis.

Authors:  H Lamlum; M Ilyas; A Rowan; S Clark; V Johnson; J Bell; I Frayling; J Efstathiou; K Pack; S Payne; R Roylance; P Gorman; D Sheer; K Neale; R Phillips; I Talbot; W Bodmer; I Tomlinson
Journal:  Nat Med       Date:  1999-09       Impact factor: 53.440

10.  Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer.

Authors:  R Roylance; P Gorman; W Harris; R Liebmann; D Barnes; A Hanby; D Sheer
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

View more
  11 in total

Review 1.  From gene mutations to tumours--stem cells in gastrointestinal carcinogenesis.

Authors:  S J Leedham; S Schier; A T Thliveris; R B Halberg; M A Newton; N A Wright
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

Review 2.  Gastrointestinal stem cells and cancer: bridging the molecular gap.

Authors:  S J Leedham; A T Thliveris; R B Halberg; M A Newton; N A Wright
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

3.  Genetic and pathologic changes associated with lymphovascular invasion of colorectal adenocarcinoma.

Authors:  Jin C Kim; Seon A Roh; Kang H Lee; Hwan Namgung; Jung R Kim; Jung S Kim
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

4.  Expression Profiles in Stage II Colon Cancer According to APC Gene Status.

Authors:  David J Birnbaum; Sophy Laibe; Anthony Ferrari; Arnaud Lagarde; Aurélie J Fabre; Geneviève Monges; Daniel Birnbaum; Sylviane Olschwang
Journal:  Transl Oncol       Date:  2012-04-01       Impact factor: 4.243

5.  There is a world beyond protein mutations: the role of non-coding RNAs in melanomagenesis.

Authors:  Rolf K Swoboda; Meenhard Herlyn
Journal:  Exp Dermatol       Date:  2013-03-12       Impact factor: 3.960

6.  A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome.

Authors:  M Clendenning; L Senter; H Hampel; K Lagerstedt Robinson; S Sun; D Buchanan; M D Walsh; M Nilbert; J Green; J Potter; A Lindblom; A de la Chapelle
Journal:  J Med Genet       Date:  2008-01-04       Impact factor: 6.318

7.  Inherited Variants in BLM and the Risk and Clinical Characteristics of Breast Cancer.

Authors:  Wojciech Kluźniak; Dominika Wokołorczyk; Bogna Rusak; Tomasz Huzarski; Aniruddh Kashyap; Klaudia Stempa; Helena Rudnicka; Anna Jakubowska; Marek Szwiec; Sylwia Morawska; Katarzyna Gliniewicz; Karina Mordak; Małgorzata Stawicka; Joanna Jarkiewicz-Tretyn; Magdalena Cechowska; Paweł Domagała; Tadeusz Dębniak; Marcin Lener; Jacek Gronwald; Jan Lubiński; Steven A Narod; Mohammad R Akbari; Cezary Cybulski
Journal:  Cancers (Basel)       Date:  2019-10-13       Impact factor: 6.639

Review 8.  Mismatch repair deficient colorectal cancer in the era of personalized treatment.

Authors:  Madeleine Hewish; Christopher J Lord; Sarah A Martin; David Cunningham; Alan Ashworth
Journal:  Nat Rev Clin Oncol       Date:  2010-02-23       Impact factor: 66.675

Review 9.  Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes.

Authors:  Viera Kútna; Valerie B O'Leary; Ehren Newman; Cyril Hoschl; Saak V Ovsepian
Journal:  Neurotherapeutics       Date:  2021-01-04       Impact factor: 7.620

10.  Systematic characterization of germline variants from the DiscovEHR study endometrial carcinoma population.

Authors:  Jason E Miller; Raghu P Metpally; Thomas N Person; Sarathbabu Krishnamurthy; Venkata Ramesh Dasari; Manu Shivakumar; Daniel R Lavage; Adam M Cook; David J Carey; Marylyn D Ritchie; Dokyoon Kim; Radhika Gogoi
Journal:  BMC Med Genomics       Date:  2019-05-03       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.